Global Antibody Drugs Market Growth 2025-2031
The global Antibody Drugs market size is predicted to grow from US$ 161990 million in 2025 to US$ 279740 million in 2031; it is expected to grow at a CAGR of 9.5% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
This report mainly focuses on antibody drugs market. Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by C?sar Milstein and Georges K?hler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Antibody Drugs Industry Forecast” looks at past sales and reviews total world Antibody Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Antibody Drugs sales for 2025 through 2031. With Antibody Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody Drugs industry.
This Insight Report provides a comprehensive analysis of the global Antibody Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibody Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antibody Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Antibody Drugs market?
What factors are driving Antibody Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antibody Drugs market opportunities vary by end market size?
How does Antibody Drugs break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
This report mainly focuses on antibody drugs market. Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by C?sar Milstein and Georges K?hler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Antibody Drugs Industry Forecast” looks at past sales and reviews total world Antibody Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Antibody Drugs sales for 2025 through 2031. With Antibody Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody Drugs industry.
This Insight Report provides a comprehensive analysis of the global Antibody Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibody Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antibody Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Monoclonal Antibodies
- Antibody-Drug Conjugates
- Polyclonal Antibodies
- Central Nervous System (CNS) Disorders
- Cancers
- Autoimmune Disorders
- Cardiovascular Diseases
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Amgen
- Bristol-Myers Squibb
- F. Hoffmann-La Roche
- Johnson & Johnson
- AbbVie
- Eli Lilly
- Pfizer
- Bayer
- GlaxoSmithKline
- Sanofi
What is the 10-year outlook for the global Antibody Drugs market?
What factors are driving Antibody Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antibody Drugs market opportunities vary by end market size?
How does Antibody Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antibody Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Antibody Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Antibody Drugs by Country/Region, 2020, 2024 & 2031
2.2 Antibody Drugs Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Antibody-Drug Conjugates
2.2.3 Polyclonal Antibodies
2.3 Antibody Drugs Sales by Type
2.3.1 Global Antibody Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Antibody Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Antibody Drugs Sale Price by Type (2020-2025)
2.4 Antibody Drugs Segment by Application
2.4.1 Central Nervous System (CNS) Disorders
2.4.2 Cancers
2.4.3 Autoimmune Disorders
2.4.4 Cardiovascular Diseases
2.5 Antibody Drugs Sales by Application
2.5.1 Global Antibody Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Antibody Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Antibody Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Antibody Drugs Breakdown Data by Company
3.1.1 Global Antibody Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Antibody Drugs Sales Market Share by Company (2020-2025)
3.2 Global Antibody Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Antibody Drugs Revenue by Company (2020-2025)
3.2.2 Global Antibody Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Antibody Drugs Sale Price by Company
3.4 Key Manufacturers Antibody Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antibody Drugs Product Location Distribution
3.4.2 Players Antibody Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTIBODY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Antibody Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Antibody Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Antibody Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antibody Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Antibody Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Antibody Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antibody Drugs Sales Growth
4.4 APAC Antibody Drugs Sales Growth
4.5 Europe Antibody Drugs Sales Growth
4.6 Middle East & Africa Antibody Drugs Sales Growth
5 AMERICAS
5.1 Americas Antibody Drugs Sales by Country
5.1.1 Americas Antibody Drugs Sales by Country (2020-2025)
5.1.2 Americas Antibody Drugs Revenue by Country (2020-2025)
5.2 Americas Antibody Drugs Sales by Type (2020-2025)
5.3 Americas Antibody Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Drugs Sales by Region
6.1.1 APAC Antibody Drugs Sales by Region (2020-2025)
6.1.2 APAC Antibody Drugs Revenue by Region (2020-2025)
6.2 APAC Antibody Drugs Sales by Type (2020-2025)
6.3 APAC Antibody Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antibody Drugs by Country
7.1.1 Europe Antibody Drugs Sales by Country (2020-2025)
7.1.2 Europe Antibody Drugs Revenue by Country (2020-2025)
7.2 Europe Antibody Drugs Sales by Type (2020-2025)
7.3 Europe Antibody Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antibody Drugs by Country
8.1.1 Middle East & Africa Antibody Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Antibody Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Antibody Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Antibody Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antibody Drugs
10.3 Manufacturing Process Analysis of Antibody Drugs
10.4 Industry Chain Structure of Antibody Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antibody Drugs Distributors
11.3 Antibody Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTIBODY DRUGS BY GEOGRAPHIC REGION
12.1 Global Antibody Drugs Market Size Forecast by Region
12.1.1 Global Antibody Drugs Forecast by Region (2026-2031)
12.1.2 Global Antibody Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antibody Drugs Forecast by Type (2026-2031)
12.7 Global Antibody Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Antibody Drugs Product Portfolios and Specifications
13.1.3 Novartis Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Antibody Drugs Product Portfolios and Specifications
13.2.3 Amgen Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Company Information
13.3.2 Bristol-Myers Squibb Antibody Drugs Product Portfolios and Specifications
13.3.3 Bristol-Myers Squibb Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bristol-Myers Squibb Main Business Overview
13.3.5 Bristol-Myers Squibb Latest Developments
13.4 F. Hoffmann-La Roche
13.4.1 F. Hoffmann-La Roche Company Information
13.4.2 F. Hoffmann-La Roche Antibody Drugs Product Portfolios and Specifications
13.4.3 F. Hoffmann-La Roche Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 F. Hoffmann-La Roche Main Business Overview
13.4.5 F. Hoffmann-La Roche Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Antibody Drugs Product Portfolios and Specifications
13.5.3 Johnson & Johnson Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 AbbVie
13.6.1 AbbVie Company Information
13.6.2 AbbVie Antibody Drugs Product Portfolios and Specifications
13.6.3 AbbVie Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 AbbVie Main Business Overview
13.6.5 AbbVie Latest Developments
13.7 Eli Lilly
13.7.1 Eli Lilly Company Information
13.7.2 Eli Lilly Antibody Drugs Product Portfolios and Specifications
13.7.3 Eli Lilly Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Eli Lilly Main Business Overview
13.7.5 Eli Lilly Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Antibody Drugs Product Portfolios and Specifications
13.8.3 Pfizer Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Bayer
13.9.1 Bayer Company Information
13.9.2 Bayer Antibody Drugs Product Portfolios and Specifications
13.9.3 Bayer Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Bayer Main Business Overview
13.9.5 Bayer Latest Developments
13.10 GlaxoSmithKline
13.10.1 GlaxoSmithKline Company Information
13.10.2 GlaxoSmithKline Antibody Drugs Product Portfolios and Specifications
13.10.3 GlaxoSmithKline Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 GlaxoSmithKline Main Business Overview
13.10.5 GlaxoSmithKline Latest Developments
13.11 Sanofi
13.11.1 Sanofi Company Information
13.11.2 Sanofi Antibody Drugs Product Portfolios and Specifications
13.11.3 Sanofi Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sanofi Main Business Overview
13.11.5 Sanofi Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antibody Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Antibody Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Antibody Drugs by Country/Region, 2020, 2024 & 2031
2.2 Antibody Drugs Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Antibody-Drug Conjugates
2.2.3 Polyclonal Antibodies
2.3 Antibody Drugs Sales by Type
2.3.1 Global Antibody Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Antibody Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Antibody Drugs Sale Price by Type (2020-2025)
2.4 Antibody Drugs Segment by Application
2.4.1 Central Nervous System (CNS) Disorders
2.4.2 Cancers
2.4.3 Autoimmune Disorders
2.4.4 Cardiovascular Diseases
2.5 Antibody Drugs Sales by Application
2.5.1 Global Antibody Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Antibody Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Antibody Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Antibody Drugs Breakdown Data by Company
3.1.1 Global Antibody Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Antibody Drugs Sales Market Share by Company (2020-2025)
3.2 Global Antibody Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Antibody Drugs Revenue by Company (2020-2025)
3.2.2 Global Antibody Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Antibody Drugs Sale Price by Company
3.4 Key Manufacturers Antibody Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antibody Drugs Product Location Distribution
3.4.2 Players Antibody Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTIBODY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Antibody Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Antibody Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Antibody Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antibody Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Antibody Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Antibody Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antibody Drugs Sales Growth
4.4 APAC Antibody Drugs Sales Growth
4.5 Europe Antibody Drugs Sales Growth
4.6 Middle East & Africa Antibody Drugs Sales Growth
5 AMERICAS
5.1 Americas Antibody Drugs Sales by Country
5.1.1 Americas Antibody Drugs Sales by Country (2020-2025)
5.1.2 Americas Antibody Drugs Revenue by Country (2020-2025)
5.2 Americas Antibody Drugs Sales by Type (2020-2025)
5.3 Americas Antibody Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Drugs Sales by Region
6.1.1 APAC Antibody Drugs Sales by Region (2020-2025)
6.1.2 APAC Antibody Drugs Revenue by Region (2020-2025)
6.2 APAC Antibody Drugs Sales by Type (2020-2025)
6.3 APAC Antibody Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antibody Drugs by Country
7.1.1 Europe Antibody Drugs Sales by Country (2020-2025)
7.1.2 Europe Antibody Drugs Revenue by Country (2020-2025)
7.2 Europe Antibody Drugs Sales by Type (2020-2025)
7.3 Europe Antibody Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antibody Drugs by Country
8.1.1 Middle East & Africa Antibody Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Antibody Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Antibody Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Antibody Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antibody Drugs
10.3 Manufacturing Process Analysis of Antibody Drugs
10.4 Industry Chain Structure of Antibody Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antibody Drugs Distributors
11.3 Antibody Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTIBODY DRUGS BY GEOGRAPHIC REGION
12.1 Global Antibody Drugs Market Size Forecast by Region
12.1.1 Global Antibody Drugs Forecast by Region (2026-2031)
12.1.2 Global Antibody Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antibody Drugs Forecast by Type (2026-2031)
12.7 Global Antibody Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Antibody Drugs Product Portfolios and Specifications
13.1.3 Novartis Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Antibody Drugs Product Portfolios and Specifications
13.2.3 Amgen Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Company Information
13.3.2 Bristol-Myers Squibb Antibody Drugs Product Portfolios and Specifications
13.3.3 Bristol-Myers Squibb Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bristol-Myers Squibb Main Business Overview
13.3.5 Bristol-Myers Squibb Latest Developments
13.4 F. Hoffmann-La Roche
13.4.1 F. Hoffmann-La Roche Company Information
13.4.2 F. Hoffmann-La Roche Antibody Drugs Product Portfolios and Specifications
13.4.3 F. Hoffmann-La Roche Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 F. Hoffmann-La Roche Main Business Overview
13.4.5 F. Hoffmann-La Roche Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Antibody Drugs Product Portfolios and Specifications
13.5.3 Johnson & Johnson Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 AbbVie
13.6.1 AbbVie Company Information
13.6.2 AbbVie Antibody Drugs Product Portfolios and Specifications
13.6.3 AbbVie Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 AbbVie Main Business Overview
13.6.5 AbbVie Latest Developments
13.7 Eli Lilly
13.7.1 Eli Lilly Company Information
13.7.2 Eli Lilly Antibody Drugs Product Portfolios and Specifications
13.7.3 Eli Lilly Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Eli Lilly Main Business Overview
13.7.5 Eli Lilly Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Antibody Drugs Product Portfolios and Specifications
13.8.3 Pfizer Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Bayer
13.9.1 Bayer Company Information
13.9.2 Bayer Antibody Drugs Product Portfolios and Specifications
13.9.3 Bayer Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Bayer Main Business Overview
13.9.5 Bayer Latest Developments
13.10 GlaxoSmithKline
13.10.1 GlaxoSmithKline Company Information
13.10.2 GlaxoSmithKline Antibody Drugs Product Portfolios and Specifications
13.10.3 GlaxoSmithKline Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 GlaxoSmithKline Main Business Overview
13.10.5 GlaxoSmithKline Latest Developments
13.11 Sanofi
13.11.1 Sanofi Company Information
13.11.2 Sanofi Antibody Drugs Product Portfolios and Specifications
13.11.3 Sanofi Antibody Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sanofi Main Business Overview
13.11.5 Sanofi Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antibody Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antibody Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Antibody-Drug Conjugates
Table 5. Major Players of Polyclonal Antibodies
Table 6. Global Antibody Drugs Sales by Type (2020-2025) & (g)
Table 7. Global Antibody Drugs Sales Market Share by Type (2020-2025)
Table 8. Global Antibody Drugs Revenue by Type (2020-2025) & ($ million)
Table 9. Global Antibody Drugs Revenue Market Share by Type (2020-2025)
Table 10. Global Antibody Drugs Sale Price by Type (2020-2025) & (USD/mg)
Table 11. Global Antibody Drugs Sale by Application (2020-2025) & (g)
Table 12. Global Antibody Drugs Sale Market Share by Application (2020-2025)
Table 13. Global Antibody Drugs Revenue by Application (2020-2025) & ($ million)
Table 14. Global Antibody Drugs Revenue Market Share by Application (2020-2025)
Table 15. Global Antibody Drugs Sale Price by Application (2020-2025) & (USD/mg)
Table 16. Global Antibody Drugs Sales by Company (2020-2025) & (g)
Table 17. Global Antibody Drugs Sales Market Share by Company (2020-2025)
Table 18. Global Antibody Drugs Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Antibody Drugs Revenue Market Share by Company (2020-2025)
Table 20. Global Antibody Drugs Sale Price by Company (2020-2025) & (USD/mg)
Table 21. Key Manufacturers Antibody Drugs Producing Area Distribution and Sales Area
Table 22. Players Antibody Drugs Products Offered
Table 23. Antibody Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Antibody Drugs Sales by Geographic Region (2020-2025) & (g)
Table 27. Global Antibody Drugs Sales Market Share Geographic Region (2020-2025)
Table 28. Global Antibody Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Antibody Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Antibody Drugs Sales by Country/Region (2020-2025) & (g)
Table 31. Global Antibody Drugs Sales Market Share by Country/Region (2020-2025)
Table 32. Global Antibody Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Antibody Drugs Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Antibody Drugs Sales by Country (2020-2025) & (g)
Table 35. Americas Antibody Drugs Sales Market Share by Country (2020-2025)
Table 36. Americas Antibody Drugs Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Antibody Drugs Sales by Type (2020-2025) & (g)
Table 38. Americas Antibody Drugs Sales by Application (2020-2025) & (g)
Table 39. APAC Antibody Drugs Sales by Region (2020-2025) & (g)
Table 40. APAC Antibody Drugs Sales Market Share by Region (2020-2025)
Table 41. APAC Antibody Drugs Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Antibody Drugs Sales by Type (2020-2025) & (g)
Table 43. APAC Antibody Drugs Sales by Application (2020-2025) & (g)
Table 44. Europe Antibody Drugs Sales by Country (2020-2025) & (g)
Table 45. Europe Antibody Drugs Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Antibody Drugs Sales by Type (2020-2025) & (g)
Table 47. Europe Antibody Drugs Sales by Application (2020-2025) & (g)
Table 48. Middle East & Africa Antibody Drugs Sales by Country (2020-2025) & (g)
Table 49. Middle East & Africa Antibody Drugs Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Antibody Drugs Sales by Type (2020-2025) & (g)
Table 51. Middle East & Africa Antibody Drugs Sales by Application (2020-2025) & (g)
Table 52. Key Market Drivers & Growth Opportunities of Antibody Drugs
Table 53. Key Market Challenges & Risks of Antibody Drugs
Table 54. Key Industry Trends of Antibody Drugs
Table 55. Antibody Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Antibody Drugs Distributors List
Table 58. Antibody Drugs Customer List
Table 59. Global Antibody Drugs Sales Forecast by Region (2026-2031) & (g)
Table 60. Global Antibody Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Antibody Drugs Sales Forecast by Country (2026-2031) & (g)
Table 62. Americas Antibody Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Antibody Drugs Sales Forecast by Region (2026-2031) & (g)
Table 64. APAC Antibody Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Antibody Drugs Sales Forecast by Country (2026-2031) & (g)
Table 66. Europe Antibody Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Antibody Drugs Sales Forecast by Country (2026-2031) & (g)
Table 68. Middle East & Africa Antibody Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Antibody Drugs Sales Forecast by Type (2026-2031) & (g)
Table 70. Global Antibody Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Antibody Drugs Sales Forecast by Application (2026-2031) & (g)
Table 72. Global Antibody Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Novartis Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis Antibody Drugs Product Portfolios and Specifications
Table 75. Novartis Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 76. Novartis Main Business
Table 77. Novartis Latest Developments
Table 78. Amgen Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Amgen Antibody Drugs Product Portfolios and Specifications
Table 80. Amgen Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 81. Amgen Main Business
Table 82. Amgen Latest Developments
Table 83. Bristol-Myers Squibb Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Bristol-Myers Squibb Antibody Drugs Product Portfolios and Specifications
Table 85. Bristol-Myers Squibb Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 86. Bristol-Myers Squibb Main Business
Table 87. Bristol-Myers Squibb Latest Developments
Table 88. F. Hoffmann-La Roche Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. F. Hoffmann-La Roche Antibody Drugs Product Portfolios and Specifications
Table 90. F. Hoffmann-La Roche Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 91. F. Hoffmann-La Roche Main Business
Table 92. F. Hoffmann-La Roche Latest Developments
Table 93. Johnson & Johnson Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & Johnson Antibody Drugs Product Portfolios and Specifications
Table 95. Johnson & Johnson Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. AbbVie Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. AbbVie Antibody Drugs Product Portfolios and Specifications
Table 100. AbbVie Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 101. AbbVie Main Business
Table 102. AbbVie Latest Developments
Table 103. Eli Lilly Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Eli Lilly Antibody Drugs Product Portfolios and Specifications
Table 105. Eli Lilly Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 106. Eli Lilly Main Business
Table 107. Eli Lilly Latest Developments
Table 108. Pfizer Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Pfizer Antibody Drugs Product Portfolios and Specifications
Table 110. Pfizer Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 111. Pfizer Main Business
Table 112. Pfizer Latest Developments
Table 113. Bayer Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Bayer Antibody Drugs Product Portfolios and Specifications
Table 115. Bayer Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 116. Bayer Main Business
Table 117. Bayer Latest Developments
Table 118. GlaxoSmithKline Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. GlaxoSmithKline Antibody Drugs Product Portfolios and Specifications
Table 120. GlaxoSmithKline Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 121. GlaxoSmithKline Main Business
Table 122. GlaxoSmithKline Latest Developments
Table 123. Sanofi Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Sanofi Antibody Drugs Product Portfolios and Specifications
Table 125. Sanofi Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 126. Sanofi Main Business
Table 127. Sanofi Latest Developments
Table 1. Antibody Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antibody Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Antibody-Drug Conjugates
Table 5. Major Players of Polyclonal Antibodies
Table 6. Global Antibody Drugs Sales by Type (2020-2025) & (g)
Table 7. Global Antibody Drugs Sales Market Share by Type (2020-2025)
Table 8. Global Antibody Drugs Revenue by Type (2020-2025) & ($ million)
Table 9. Global Antibody Drugs Revenue Market Share by Type (2020-2025)
Table 10. Global Antibody Drugs Sale Price by Type (2020-2025) & (USD/mg)
Table 11. Global Antibody Drugs Sale by Application (2020-2025) & (g)
Table 12. Global Antibody Drugs Sale Market Share by Application (2020-2025)
Table 13. Global Antibody Drugs Revenue by Application (2020-2025) & ($ million)
Table 14. Global Antibody Drugs Revenue Market Share by Application (2020-2025)
Table 15. Global Antibody Drugs Sale Price by Application (2020-2025) & (USD/mg)
Table 16. Global Antibody Drugs Sales by Company (2020-2025) & (g)
Table 17. Global Antibody Drugs Sales Market Share by Company (2020-2025)
Table 18. Global Antibody Drugs Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Antibody Drugs Revenue Market Share by Company (2020-2025)
Table 20. Global Antibody Drugs Sale Price by Company (2020-2025) & (USD/mg)
Table 21. Key Manufacturers Antibody Drugs Producing Area Distribution and Sales Area
Table 22. Players Antibody Drugs Products Offered
Table 23. Antibody Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Antibody Drugs Sales by Geographic Region (2020-2025) & (g)
Table 27. Global Antibody Drugs Sales Market Share Geographic Region (2020-2025)
Table 28. Global Antibody Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Antibody Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Antibody Drugs Sales by Country/Region (2020-2025) & (g)
Table 31. Global Antibody Drugs Sales Market Share by Country/Region (2020-2025)
Table 32. Global Antibody Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Antibody Drugs Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Antibody Drugs Sales by Country (2020-2025) & (g)
Table 35. Americas Antibody Drugs Sales Market Share by Country (2020-2025)
Table 36. Americas Antibody Drugs Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Antibody Drugs Sales by Type (2020-2025) & (g)
Table 38. Americas Antibody Drugs Sales by Application (2020-2025) & (g)
Table 39. APAC Antibody Drugs Sales by Region (2020-2025) & (g)
Table 40. APAC Antibody Drugs Sales Market Share by Region (2020-2025)
Table 41. APAC Antibody Drugs Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Antibody Drugs Sales by Type (2020-2025) & (g)
Table 43. APAC Antibody Drugs Sales by Application (2020-2025) & (g)
Table 44. Europe Antibody Drugs Sales by Country (2020-2025) & (g)
Table 45. Europe Antibody Drugs Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Antibody Drugs Sales by Type (2020-2025) & (g)
Table 47. Europe Antibody Drugs Sales by Application (2020-2025) & (g)
Table 48. Middle East & Africa Antibody Drugs Sales by Country (2020-2025) & (g)
Table 49. Middle East & Africa Antibody Drugs Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Antibody Drugs Sales by Type (2020-2025) & (g)
Table 51. Middle East & Africa Antibody Drugs Sales by Application (2020-2025) & (g)
Table 52. Key Market Drivers & Growth Opportunities of Antibody Drugs
Table 53. Key Market Challenges & Risks of Antibody Drugs
Table 54. Key Industry Trends of Antibody Drugs
Table 55. Antibody Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Antibody Drugs Distributors List
Table 58. Antibody Drugs Customer List
Table 59. Global Antibody Drugs Sales Forecast by Region (2026-2031) & (g)
Table 60. Global Antibody Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Antibody Drugs Sales Forecast by Country (2026-2031) & (g)
Table 62. Americas Antibody Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Antibody Drugs Sales Forecast by Region (2026-2031) & (g)
Table 64. APAC Antibody Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Antibody Drugs Sales Forecast by Country (2026-2031) & (g)
Table 66. Europe Antibody Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Antibody Drugs Sales Forecast by Country (2026-2031) & (g)
Table 68. Middle East & Africa Antibody Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Antibody Drugs Sales Forecast by Type (2026-2031) & (g)
Table 70. Global Antibody Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Antibody Drugs Sales Forecast by Application (2026-2031) & (g)
Table 72. Global Antibody Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Novartis Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis Antibody Drugs Product Portfolios and Specifications
Table 75. Novartis Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 76. Novartis Main Business
Table 77. Novartis Latest Developments
Table 78. Amgen Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Amgen Antibody Drugs Product Portfolios and Specifications
Table 80. Amgen Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 81. Amgen Main Business
Table 82. Amgen Latest Developments
Table 83. Bristol-Myers Squibb Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Bristol-Myers Squibb Antibody Drugs Product Portfolios and Specifications
Table 85. Bristol-Myers Squibb Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 86. Bristol-Myers Squibb Main Business
Table 87. Bristol-Myers Squibb Latest Developments
Table 88. F. Hoffmann-La Roche Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. F. Hoffmann-La Roche Antibody Drugs Product Portfolios and Specifications
Table 90. F. Hoffmann-La Roche Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 91. F. Hoffmann-La Roche Main Business
Table 92. F. Hoffmann-La Roche Latest Developments
Table 93. Johnson & Johnson Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & Johnson Antibody Drugs Product Portfolios and Specifications
Table 95. Johnson & Johnson Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. AbbVie Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. AbbVie Antibody Drugs Product Portfolios and Specifications
Table 100. AbbVie Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 101. AbbVie Main Business
Table 102. AbbVie Latest Developments
Table 103. Eli Lilly Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Eli Lilly Antibody Drugs Product Portfolios and Specifications
Table 105. Eli Lilly Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 106. Eli Lilly Main Business
Table 107. Eli Lilly Latest Developments
Table 108. Pfizer Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Pfizer Antibody Drugs Product Portfolios and Specifications
Table 110. Pfizer Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 111. Pfizer Main Business
Table 112. Pfizer Latest Developments
Table 113. Bayer Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Bayer Antibody Drugs Product Portfolios and Specifications
Table 115. Bayer Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 116. Bayer Main Business
Table 117. Bayer Latest Developments
Table 118. GlaxoSmithKline Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. GlaxoSmithKline Antibody Drugs Product Portfolios and Specifications
Table 120. GlaxoSmithKline Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 121. GlaxoSmithKline Main Business
Table 122. GlaxoSmithKline Latest Developments
Table 123. Sanofi Basic Information, Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Sanofi Antibody Drugs Product Portfolios and Specifications
Table 125. Sanofi Antibody Drugs Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 126. Sanofi Main Business
Table 127. Sanofi Latest Developments
LIST OF FIGURES
Figure 1. Picture of Antibody Drugs
Figure 2. Antibody Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antibody Drugs Sales Growth Rate 2020-2031 (g)
Figure 7. Global Antibody Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antibody Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antibody Drugs Sales Market Share by Country/Region (2024)
Figure 10. Antibody Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Monoclonal Antibodies
Figure 12. Product Picture of Antibody-Drug Conjugates
Figure 13. Product Picture of Polyclonal Antibodies
Figure 14. Global Antibody Drugs Sales Market Share by Type in 2025
Figure 15. Global Antibody Drugs Revenue Market Share by Type (2020-2025)
Figure 16. Antibody Drugs Consumed in Central Nervous System (CNS) Disorders
Figure 17. Global Antibody Drugs Market: Central Nervous System (CNS) Disorders (2020-2025) & (g)
Figure 18. Antibody Drugs Consumed in Cancers
Figure 19. Global Antibody Drugs Market: Cancers (2020-2025) & (g)
Figure 20. Antibody Drugs Consumed in Autoimmune Disorders
Figure 21. Global Antibody Drugs Market: Autoimmune Disorders (2020-2025) & (g)
Figure 22. Antibody Drugs Consumed in Cardiovascular Diseases
Figure 23. Global Antibody Drugs Market: Cardiovascular Diseases (2020-2025) & (g)
Figure 24. Global Antibody Drugs Sale Market Share by Application (2024)
Figure 25. Global Antibody Drugs Revenue Market Share by Application in 2025
Figure 26. Antibody Drugs Sales by Company in 2025 (g)
Figure 27. Global Antibody Drugs Sales Market Share by Company in 2025
Figure 28. Antibody Drugs Revenue by Company in 2025 ($ millions)
Figure 29. Global Antibody Drugs Revenue Market Share by Company in 2025
Figure 30. Global Antibody Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Antibody Drugs Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Antibody Drugs Sales 2020-2025 (g)
Figure 33. Americas Antibody Drugs Revenue 2020-2025 ($ millions)
Figure 34. APAC Antibody Drugs Sales 2020-2025 (g)
Figure 35. APAC Antibody Drugs Revenue 2020-2025 ($ millions)
Figure 36. Europe Antibody Drugs Sales 2020-2025 (g)
Figure 37. Europe Antibody Drugs Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Antibody Drugs Sales 2020-2025 (g)
Figure 39. Middle East & Africa Antibody Drugs Revenue 2020-2025 ($ millions)
Figure 40. Americas Antibody Drugs Sales Market Share by Country in 2025
Figure 41. Americas Antibody Drugs Revenue Market Share by Country (2020-2025)
Figure 42. Americas Antibody Drugs Sales Market Share by Type (2020-2025)
Figure 43. Americas Antibody Drugs Sales Market Share by Application (2020-2025)
Figure 44. United States Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Antibody Drugs Sales Market Share by Region in 2025
Figure 49. APAC Antibody Drugs Revenue Market Share by Region (2020-2025)
Figure 50. APAC Antibody Drugs Sales Market Share by Type (2020-2025)
Figure 51. APAC Antibody Drugs Sales Market Share by Application (2020-2025)
Figure 52. China Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. India Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Antibody Drugs Sales Market Share by Country in 2025
Figure 60. Europe Antibody Drugs Revenue Market Share by Country (2020-2025)
Figure 61. Europe Antibody Drugs Sales Market Share by Type (2020-2025)
Figure 62. Europe Antibody Drugs Sales Market Share by Application (2020-2025)
Figure 63. Germany Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. France Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Antibody Drugs Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Antibody Drugs Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Antibody Drugs Sales Market Share by Application (2020-2025)
Figure 71. Egypt Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Antibody Drugs in 2025
Figure 77. Manufacturing Process Analysis of Antibody Drugs
Figure 78. Industry Chain Structure of Antibody Drugs
Figure 79. Channels of Distribution
Figure 80. Global Antibody Drugs Sales Market Forecast by Region (2026-2031)
Figure 81. Global Antibody Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Antibody Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Antibody Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Antibody Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Antibody Drugs Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Antibody Drugs
Figure 2. Antibody Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antibody Drugs Sales Growth Rate 2020-2031 (g)
Figure 7. Global Antibody Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antibody Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antibody Drugs Sales Market Share by Country/Region (2024)
Figure 10. Antibody Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Monoclonal Antibodies
Figure 12. Product Picture of Antibody-Drug Conjugates
Figure 13. Product Picture of Polyclonal Antibodies
Figure 14. Global Antibody Drugs Sales Market Share by Type in 2025
Figure 15. Global Antibody Drugs Revenue Market Share by Type (2020-2025)
Figure 16. Antibody Drugs Consumed in Central Nervous System (CNS) Disorders
Figure 17. Global Antibody Drugs Market: Central Nervous System (CNS) Disorders (2020-2025) & (g)
Figure 18. Antibody Drugs Consumed in Cancers
Figure 19. Global Antibody Drugs Market: Cancers (2020-2025) & (g)
Figure 20. Antibody Drugs Consumed in Autoimmune Disorders
Figure 21. Global Antibody Drugs Market: Autoimmune Disorders (2020-2025) & (g)
Figure 22. Antibody Drugs Consumed in Cardiovascular Diseases
Figure 23. Global Antibody Drugs Market: Cardiovascular Diseases (2020-2025) & (g)
Figure 24. Global Antibody Drugs Sale Market Share by Application (2024)
Figure 25. Global Antibody Drugs Revenue Market Share by Application in 2025
Figure 26. Antibody Drugs Sales by Company in 2025 (g)
Figure 27. Global Antibody Drugs Sales Market Share by Company in 2025
Figure 28. Antibody Drugs Revenue by Company in 2025 ($ millions)
Figure 29. Global Antibody Drugs Revenue Market Share by Company in 2025
Figure 30. Global Antibody Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Antibody Drugs Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Antibody Drugs Sales 2020-2025 (g)
Figure 33. Americas Antibody Drugs Revenue 2020-2025 ($ millions)
Figure 34. APAC Antibody Drugs Sales 2020-2025 (g)
Figure 35. APAC Antibody Drugs Revenue 2020-2025 ($ millions)
Figure 36. Europe Antibody Drugs Sales 2020-2025 (g)
Figure 37. Europe Antibody Drugs Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Antibody Drugs Sales 2020-2025 (g)
Figure 39. Middle East & Africa Antibody Drugs Revenue 2020-2025 ($ millions)
Figure 40. Americas Antibody Drugs Sales Market Share by Country in 2025
Figure 41. Americas Antibody Drugs Revenue Market Share by Country (2020-2025)
Figure 42. Americas Antibody Drugs Sales Market Share by Type (2020-2025)
Figure 43. Americas Antibody Drugs Sales Market Share by Application (2020-2025)
Figure 44. United States Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Antibody Drugs Sales Market Share by Region in 2025
Figure 49. APAC Antibody Drugs Revenue Market Share by Region (2020-2025)
Figure 50. APAC Antibody Drugs Sales Market Share by Type (2020-2025)
Figure 51. APAC Antibody Drugs Sales Market Share by Application (2020-2025)
Figure 52. China Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. India Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Antibody Drugs Sales Market Share by Country in 2025
Figure 60. Europe Antibody Drugs Revenue Market Share by Country (2020-2025)
Figure 61. Europe Antibody Drugs Sales Market Share by Type (2020-2025)
Figure 62. Europe Antibody Drugs Sales Market Share by Application (2020-2025)
Figure 63. Germany Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. France Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Antibody Drugs Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Antibody Drugs Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Antibody Drugs Sales Market Share by Application (2020-2025)
Figure 71. Egypt Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Antibody Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Antibody Drugs in 2025
Figure 77. Manufacturing Process Analysis of Antibody Drugs
Figure 78. Industry Chain Structure of Antibody Drugs
Figure 79. Channels of Distribution
Figure 80. Global Antibody Drugs Sales Market Forecast by Region (2026-2031)
Figure 81. Global Antibody Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Antibody Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Antibody Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Antibody Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Antibody Drugs Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Pica Eating Disorder Treatment Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
100 pages
Global Epithelial Cell Adhesion Molecule Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
88 pages
Global Plasma Thawing Systems Market Growth 2024-2030
US$ 3,660.00
October 2024
112 pages
Global Organ Care Products Market Growth 2023-2029
US$ 3,660.00
March 2023
79 pages
